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A B D C Figure S2 . Thermostability of 2G12 and cDNA-mRNA duplex of the library fusions. (A) Analyses of the interaction between 2G12 and gp120 using BLitz with Dip and Read Ni-NTA Biosensors (ForteBio). 25 μg/ml His 6 -tagged gp120 (HIV-1 JRFL) (Immune Technology) was loaded on equilibrated Ni-NTA sensors for 3 min and then the sensors were equilibrated with selection buffer for 30 s. The gp120-loaded sensors were used to associate with the native 2G12 or the 2G12 heated at 70 °C or 95 °C, chilled on ice for 5 min and incubated at room temperature in selection buffer before loading. The time of the 2G12 association and dissociation steps in selection buffer were 2 min. (B) 100 nM 2G12 was incubated with 6 mg/ml protein G magnetic beads in selection buffer for 1 hr and the supernatant was removed (1st sup). The beads were resupended in selection buffer and heated at 70 °C for 30 min, chilled on ice for 5 min, and incubated at room temperature for 10 min. Then, the supernatant (2nd sup) was removed and the 2G12 bound to the beads were eluted out by boil in Laemmli sample buffer (bead bound). The supernatants and bead bound fraction were analyzed with the controls of amounts of input to the beads using 4-20 % SDS-PAGE without addition of reducing agent. The gel was silver-stained. (D) Same experiment as (B) using 12 mg/ml protein A magnetic beads except that the incubation time at 70 °C was 20 min. (D) The 35 S-cysteine labeled library fusions (50 fmol) for selection round 1 were heated at 95 °C for 2 min or 70 °C for 20 min and chilled on ice before applied to 7.5 % SDS-PAGE. The gel was analyzed by autoradiography. Figure S3 . The MALDI-TOF-MS spectra of the translated peptides. An arrow head indicates the peak of the average mass of the peptide ion. The asterisks show the three representative impurities derived from the PURE system as observed in the "-RNA" control, in which translation reactions were done without mRNA and purified with Ni-NTA. The MALDI-TOF-MS was done in linear mode and calibrated with external standards. All observed masses (Obs.) corresponded to their calculated masses (Calc.) within a range of the potential error (0.05 % accuracy) allowed in this system according to the instruction manual. After coupling and after Fmoc deprotection, the resin was washed with 20 ml of DMF at a flow rate of 10 ml/min. Fmoc deprotection was carried out at flow rate of 10 ml/min. Fmoc deprotection solution was 20% piperidine in DMF up until the coupling of aspartic acid, after which a solution of 19% piperidine/1% formic acid in DMF was used to prevent aspartimide formation.
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Fmoc-Cys(StBu)-OH and Fmoc-HPG-OH were coupled outside of the reactor. Swelled resin was transferred to a 15 mL conical tube with a stir bar. 0.15 mmol amino acid and 0.15 mmol HATU were dissolved in 425 μL DMF, and 75 μL DIPEA was added just before adding to resin. The coupling reaction was allowed to take place under nitrogen for 10 minutes at 60 °C with stirring. After the reaction, the resin was transferred to the reactor for washing and Fmoc deprotection. After peptide synthesis was complete, the N-terminus was formylated. The swelled resin was transferred to a 15 ml conical tube with a stir bar. 0.25 mmol 4-nitrophenylformate was dissolved in 632 μl DMF (0.33 M final). 125 μL DIPEA (0.86 M final) was added just before addition. Formylation was allowed to occur at 60 °C for 8 minutes while stirring under nitrogen. Next, the supernatant was removed, fresh reagents were added, and formylation was repeated. This was done again for a total of 3 -8 minute periods. After the reaction, the resin was washed with DMF 5 x 10 ml and DCM 3 x 10 ml.
The peptide was cleaved from the resin with 10 ml of a cleavage cocktail B containing 87.5/5/5/2.5 TFA/phenol/water/TIPS. The resin and cocktail were tumbled at room temperature for 90 minutes. The resin was filtered and washed 3 x 4 ml DCM. The filtrate was concentrated by rotary evaporation and transferred to a 15 ml conical tube. The peptide was triturated with 5 x 10 ml cold ether to give 35 mg crude peptide.
4.5 mg of crude peptide was purified by HPLC on a Waters Symmetry300 C4 column (4.6x250mm, 5 μm particle size) following a 98% A/2% B to 58% A/42% B gradient over 60 minutes with a flow rate of 4 ml/min, where solvent A is water/0.1% formic acid and solvent B is acetonitrile/0.1% formic acid. S16 SI 
